Penny S. Reynolds
Research Subjects
Penny S. Reynolds has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Kevin R. Ward
3 shared publicationsR. Wayne Barbee
3 shared publications- Bruce D. Spiess
From the Departments of Physiology (J.D.R., C.S.J.), Anesthesiology (P.S.R., B.D.), and Biology (L.G.S.), Virginia Commonwealth University, Richmond, Virginia
2 shared publications - Alden H. Newcomb
From the Departments of Physiology (J.D.R., C.S.J.), Anesthesiology (P.S.R., B.D.), and Biology (L.G.S.), Virginia Commonwealth University, Richmond, Virginia
1 shared publication Bruce D. Spiess
Department of Anesthesiology, Virginia Commonwealth University Medical Center, Richmond, Virginia
1 shared publication- Christopher S. Josef
Clairyon, La Jolla, CA
1 shared publication
Latest Publications
- 1 December 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 199 (2) , 536-544
Hextend–perfluorocarbon cocktail inhibits mean arterial pressure response in a rabbit shock model
- 1 December 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 199 (2) , 536-544
Hextend–perfluorocarbon cocktail inhibits mean arterial pressure response in a rabbit shock model
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 79 (4) , S116-S120
Preclinical evaluation of injectable reduced hydroxocobalamin as an antidote to acute carbon monoxide poisoning
BACKGROUND Current management of acute inhalational carbon monoxide (CO) toxicity includes hyperbaric or normobaric O2 therapy. However, efficacy has not been established. The purpose of this study was to establish therapeutic proof of concept for a novel injectable antidote consisting of the combination of hydroxocobalamin and ascorbic acid into a reduced form (B12r) as demonstrated by clinically significant increase (>500 ppm) in CO2 production, reduced carboxyhemoglobin (COHgb) half-life (COHgb t1/2), and increased cerebral O2 delivery and attenuation of CO-induced microglial damage in a preclinical rodent model of CO toxicity. METHODS B12r-mediated conversion of CO to CO2 and COHgb t1/2 in human blood were measured by gas analysis and Raman resonance spectroscopy. Rats were exposed to either air or CO and then injected with saline or B12r. Cognitive assessment was tested in a Morris water maze. Brain oxygenation was measured with Licox. Brain histology was assessed by fluorescent antibody markers and cell counts. RESULTS B12r resulted in significant CO2 production (1,170 ppm), compared with controls. COHgb t1/2 was reduced from 33 minutes (normal saline) to 17.5 (p < 0.001). In rat models, severe CO-induced brain hypoxia (PbtO2, 18 mm Hg) was followed by significant reduction in τ25 to 12 minutes for B12r rats versus 40 minutes for normal saline–treated rats (p < 0.0001). There was major attenuation of CO-induced microglial damage, although cognitive performance differences were minimal. CONCLUSION Our preclinical data suggest that the novel synergism of hydroxocobalamin with ascorbic acid has the potential to extract CO through conversion to CO2, independently of high-flow or high-pressure O2. This resulted in a clinically significant off-gassing of CO2 at levels five to eight times greater than those of controls, a clinically significant reduction in COHgb half-life, and evidence of increased brain oxygenation and amelioration of myoglial damage in rat models. Reduced hydroxocobalamin has major potential as an injectable antidote for CO toxicity
- 1 October 2015
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 79 (4) , S116-S120
Preclinical evaluation of injectable reduced hydroxocobalamin as an antidote to acute carbon monoxide poisoning
BACKGROUND Current management of acute inhalational carbon monoxide (CO) toxicity includes hyperbaric or normobaric O2 therapy. However, efficacy has not been established. The purpose of this study was to establish therapeutic proof of concept for a novel injectable antidote consisting of the combination of hydroxocobalamin and ascorbic acid into a reduced form (B12r) as demonstrated by clinically significant increase (>500 ppm) in CO2 production, reduced carboxyhemoglobin (COHgb) half-life (COHgb t1/2), and increased cerebral O2 delivery and attenuation of CO-induced microglial damage in a preclinical rodent model of CO toxicity. METHODS B12r-mediated conversion of CO to CO2 and COHgb t1/2 in human blood were measured by gas analysis and Raman resonance spectroscopy. Rats were exposed to either air or CO and then injected with saline or B12r. Cognitive assessment was tested in a Morris water maze. Brain oxygenation was measured with Licox. Brain histology was assessed by fluorescent antibody markers and cell counts. RESULTS B12r resulted in significant CO2 production (1,170 ppm), compared with controls. COHgb t1/2 was reduced from 33 minutes (normal saline) to 17.5 (p < 0.001). In rat models, severe CO-induced brain hypoxia (PbtO2, 18 mm Hg) was followed by significant reduction in τ25 to 12 minutes for B12r rats versus 40 minutes for normal saline–treated rats (p < 0.0001). There was major attenuation of CO-induced microglial damage, although cognitive performance differences were minimal. CONCLUSION Our preclinical data suggest that the novel synergism of hydroxocobalamin with ascorbic acid has the potential to extract CO through conversion to CO2, independently of high-flow or high-pressure O2. This resulted in a clinically significant off-gassing of CO2 at levels five to eight times greater than those of controls, a clinically significant reduction in COHgb half-life, and evidence of increased brain oxygenation and amelioration of myoglial damage in rat models. Reduced hydroxocobalamin has major potential as an injectable antidote for CO toxicity
- Open Access
- 30 July 2015
- Published by Springer Nature in Trials
- Vol. 16 (1) , 321
Prehospital use of plasma in traumatic hemorrhage (The PUPTH Trial): study protocol for a randomised controlled trial
Severe traumatic injury and haemorrhagic shock are frequently associated with disruptions of coagulation function (such as trauma-induced coagulopathy TIC) and activation of inflammatory cascades. These pathologies may be exacerbated by current standard of care resuscitation protocols. Observational studies suggest early administration of plasma to severely-injured haemorrhaging patients may correct TIC, minimise inflammation, and improve survival. The proposed randomised clinical trial will evaluate the clinical effectiveness of pre-hospital plasma administration compared with standard- of-care crystalloid resuscitation in severely-injured patients with major traumatic haemorrhage. This is a prospective, randomized, open-label, non-blinded trial to determine the effect of pre-hospital administration of thawed plasma (TP) on mortality, morbidity, transfusion requirements, coagulation, and inflammatory response in severely-injured bleeding trauma patients. Two hundred and ten eligible adult trauma patients will be randomised to receive either two units of plasma, to be administered in-field, vs standard of care normal saline (NS). Main analyses will compare subjects allocated to TP to those allocated to NS, on an intention-to-treat basis. Primary outcome measure is all-cause 30-day mortality. Secondary outcome measures include coagulation and lipidomic/pro-inflammatory marker responses, volume of resuscitation fluids (crystalloid, colloid) and blood products administered, and major hospital outcomes (e.g. incidence of MSOF, length of ICU stay, length of hospital stay). This study is part of a US Department of Defense (DoD)-funded multi-institutional investigation, conducted independently of, but in parallel with, the University of Pittsburgh and University of Denver. Demonstration of significant reductions in mortality and coagulopathic/inflammatory-related morbidities as a result of pre-hospital plasma administration would be of considerable clinical importance for the management of haemorrhagic shock in both civilian and military populations. ClinicalTrials.gov: NCT02303964 on 28 November 2014
- 30 July 2015
- Published by Springer Nature in Trials
- Vol. 16 (1) , 321
Open AccessPrehospital use of plasma in traumatic hemorrhage (The PUPTH Trial): study protocol for a randomised controlled trial
Severe traumatic injury and haemorrhagic shock are frequently associated with disruptions of coagulation function (such as trauma-induced coagulopathy TIC) and activation of inflammatory cascades. These pathologies may be exacerbated by current standard of care resuscitation protocols. Observational studies suggest early administration of plasma to severely-injured haemorrhaging patients may correct TIC, minimise inflammation, and improve survival. The proposed randomised clinical trial will evaluate the clinical effectiveness of pre-hospital plasma administration compared with standard- of-care crystalloid resuscitation in severely-injured patients with major traumatic haemorrhage. This is a prospective, randomized, open-label, non-blinded trial to determine the effect of pre-hospital administration of thawed plasma (TP) on mortality, morbidity, transfusion requirements, coagulation, and inflammatory response in severely-injured bleeding trauma patients. Two hundred and ten eligible adult trauma patients will be randomised to receive either two units of plasma, to be administered in-field, vs standard of care normal saline (NS). Main analyses will compare subjects allocated to TP to those allocated to NS, on an intention-to-treat basis. Primary outcome measure is all-cause 30-day mortality. Secondary outcome measures include coagulation and lipidomic/pro-inflammatory marker responses, volume of resuscitation fluids (crystalloid, colloid) and blood products administered, and major hospital outcomes (e.g. incidence of MSOF, length of ICU stay, length of hospital stay). This study is part of a US Department of Defense (DoD)-funded multi-institutional investigation, conducted independently of, but in parallel with, the University of Pittsburgh and University of Denver. Demonstration of significant reductions in mortality and coagulopathic/inflammatory-related morbidities as a result of pre-hospital plasma administration would be of considerable clinical importance for the management of haemorrhagic shock in both civilian and military populations. ClinicalTrials.gov: NCT02303964 on 28 November 2014
- 19 December 2013
- Published by Springer Nature
- p. 411-433
Low Volume Resuscitation with HBOCs in Hemorrhagic Shock
- 19 December 2013
- Published by Springer Nature
- p. 411-433
Low Volume Resuscitation with HBOCs in Hemorrhagic Shock
- 31 January 2012
- Published by Elsevier in Resuscitation
- Vol. 83 (1) , 16-17
Twenty years after: Do animal trials inform clinical resuscitation research?
- 31 January 2012
- Published by Elsevier in Resuscitation
- Vol. 83 (1) , 16-17
Twenty years after: Do animal trials inform clinical resuscitation research?
- Open Access
Understanding thermoregulatory transitions during haemorrhage by piecewise regression
Transition points are common in physiological processes. However the transition between normothermia and hypothermia during haemorrhagic shock has rarely been systematically quantified from intensive time series data. We estimated the critical transition point (CTP) and provided confidence intervals for core body temperature response to acute severe haemorrhage in a conscious rat model. Estimates were obtained by traditional piecewise linear regression (broken stick model) and compared to those from the more novel bent cable regression. Bent cable regression relaxes the assumption of an abrupt point transition, and thus allows the capture of a potentially gradual transition phase; the broken stick is a special case of the bent cable model. We calculated two types of confidence intervals, assuming either independent or autoregressive structure for the residuals. In spite of the severity of the haemorrhage, median temperature change was minor (0.8 C; IQR 0.57-1.31 C) and only four of 38 rats were clinically hypothermic (core temperature < 35 C). However, a transition could be estimated for 23 rats. Bent cable fits were superior when the transition appeared to be gradual rather than abrupt. In all cases, assuming independence gave incorrect uncertainty estimates of CTP. For 15 animals, neither model could be fitted because of irregular temperature profiles that did not conform to the assumption of a single transition. Arbitrary imposition of broken stick fits on a gradual transition profile and assuming independent rather than autocorrelated error may result in misleading estimates of CTP. Identification of the onset of irreversible shock will require further quantification of appropriate time-dependent physiological variables and their behaviour during haemorrhage.
Open AccessUnderstanding thermoregulatory transitions during haemorrhage by piecewise regression
Transition points are common in physiological processes. However the transition between normothermia and hypothermia during haemorrhagic shock has rarely been systematically quantified from intensive time series data. We estimated the critical transition point (CTP) and provided confidence intervals for core body temperature response to acute severe haemorrhage in a conscious rat model. Estimates were obtained by traditional piecewise linear regression (broken stick model) and compared to those from the more novel bent cable regression. Bent cable regression relaxes the assumption of an abrupt point transition, and thus allows the capture of a potentially gradual transition phase; the broken stick is a special case of the bent cable model. We calculated two types of confidence intervals, assuming either independent or autoregressive structure for the residuals. In spite of the severity of the haemorrhage, median temperature change was minor (0.8 C; IQR 0.57-1.31 C) and only four of 38 rats were clinically hypothermic (core temperature < 35 C). However, a transition could be estimated for 23 rats. Bent cable fits were superior when the transition appeared to be gradual rather than abrupt. In all cases, assuming independence gave incorrect uncertainty estimates of CTP. For 15 animals, neither model could be fitted because of irregular temperature profiles that did not conform to the assumption of a single transition. Arbitrary imposition of broken stick fits on a gradual transition profile and assuming independent rather than autocorrelated error may result in misleading estimates of CTP. Identification of the onset of irreversible shock will require further quantification of appropriate time-dependent physiological variables and their behaviour during haemorrhage.
- 1 April 2010
- Published by Wolters Kluwer Health in Shock
- Vol. 33 (4) , 442-449
STRATEGIES OF EXPERIMENT STANDARDIZATION AND RESPONSE OPTIMIZATION IN A RAT MODEL OF HEMORRHAGIC SHOCK AND CHRONIC HYPERTENSION
Exploratory pilot studies are crucial to best practice in research but are frequently conducted without a systematic method for maximizing the amount and quality of information obtained. We describe the use of response surface regression models and simultaneous optimization methods to develop a rat model of hemorrhagic shock in the context of chronic hypertension, a clinically relevant comorbidity. Response surface regression model was applied to determine optimal levels of two inputs--dietary NaCl concentration (0.49%, 4%, and 8%) and time on the diet (4, 6, 8 weeks)--to achieve clinically realistic and stable target measures of systolic blood pressure while simultaneously maximizing critical oxygen delivery (a measure of vulnerability to hemorrhagic shock) and body mass M. Simultaneous optimization of the three response variables was performed though a dimensionality reduction strategy involving calculation of a single aggregate measure, the "desirability" function. Optimal conditions for inducing systolic blood pressure of 208 mmHg, critical oxygen delivery of 4.03 mL/min, and M of 290 g were determined to be 4% [NaCl] for 5 weeks. Rats on the 8% diet did not survive past 7 weeks. Response surface regression model and simultaneous optimization method techniques are commonly used in process engineering but have found little application to date in animal pilot studies. These methods will ensure both the scientific and ethical integrity of experimental trials involving animals and provide powerful tools for the development of novel models of clinically interacting comorbidities with shock.
- 1 April 2010
- Published by Wolters Kluwer Health in Shock
- Vol. 33 (4) , 442-449
STRATEGIES OF EXPERIMENT STANDARDIZATION AND RESPONSE OPTIMIZATION IN A RAT MODEL OF HEMORRHAGIC SHOCK AND CHRONIC HYPERTENSION
Exploratory pilot studies are crucial to best practice in research but are frequently conducted without a systematic method for maximizing the amount and quality of information obtained. We describe the use of response surface regression models and simultaneous optimization methods to develop a rat model of hemorrhagic shock in the context of chronic hypertension, a clinically relevant comorbidity. Response surface regression model was applied to determine optimal levels of two inputs--dietary NaCl concentration (0.49%, 4%, and 8%) and time on the diet (4, 6, 8 weeks)--to achieve clinically realistic and stable target measures of systolic blood pressure while simultaneously maximizing critical oxygen delivery (a measure of vulnerability to hemorrhagic shock) and body mass M. Simultaneous optimization of the three response variables was performed though a dimensionality reduction strategy involving calculation of a single aggregate measure, the "desirability" function. Optimal conditions for inducing systolic blood pressure of 208 mmHg, critical oxygen delivery of 4.03 mL/min, and M of 290 g were determined to be 4% [NaCl] for 5 weeks. Rats on the 8% diet did not survive past 7 weeks. Response surface regression model and simultaneous optimization method techniques are commonly used in process engineering but have found little application to date in animal pilot studies. These methods will ensure both the scientific and ethical integrity of experimental trials involving animals and provide powerful tools for the development of novel models of clinically interacting comorbidities with shock.
- 1 July 2008
- Published by Wolters Kluwer Health in Shock
- Vol. 30 (1) , 48-55
LACTATE PROFILES AS A RESUSCITATION ASSESSMENT TOOL IN A RAT MODEL OF BATTLEFIELD HEMORRHAGE RESUSCITATION
Time profiles of arterial lactate concentrations have been proposed as markers for both the degree of physiological derangement during shock and effectiveness of clinical resuscitation, but have not been evaluated for use in short-term experimental protocols. We developed two quantitative mixed models of sequential arterial lactate concentrations to evaluate competing low-volume (<4 mL/kg) battlefield resuscitation therapies in a rat model of acute severe hemorrhagic shock: a simple linear additive model and a nonlinear mechanistic model that described lactate profiles in a continuous trajectory with a defined turning point. Data were obtained during a study evaluating a novel hemoglobin polymer (OxyVita) in a cocktail of hypertonic saline and Hextend as an alternative to standard Hextend. Fluids were either infused by titration to a mean systolic pressure of 60 mmHg or as a single bolus. Parameter estimates derived from both models were assessed for evidence of treatment efficacy and as indicators of short-term survival. A cocktail of hypertonic saline and Hextend was superior to standard Hextend in enhancing survival; however, lactate profiles did not differ between treatments. Regardless of resuscitation regimen, animals surviving to at least 60 min posthemorrhage can be discriminated from nonsurvivors by significantly lower peak lactates (a difference of at least 3 mM; P < 0.001), and all survivors exhibited a decline in lactate with resuscitation. Sequential measurements of lactate over relatively short time frames during resuscitation are of value in assessing both response to resuscitation and short-term mortality.
- 1 July 2008
- Published by Wolters Kluwer Health in Shock
- Vol. 30 (1) , 48-55
LACTATE PROFILES AS A RESUSCITATION ASSESSMENT TOOL IN A RAT MODEL OF BATTLEFIELD HEMORRHAGE RESUSCITATION
Time profiles of arterial lactate concentrations have been proposed as markers for both the degree of physiological derangement during shock and effectiveness of clinical resuscitation, but have not been evaluated for use in short-term experimental protocols. We developed two quantitative mixed models of sequential arterial lactate concentrations to evaluate competing low-volume (<4 mL/kg) battlefield resuscitation therapies in a rat model of acute severe hemorrhagic shock: a simple linear additive model and a nonlinear mechanistic model that described lactate profiles in a continuous trajectory with a defined turning point. Data were obtained during a study evaluating a novel hemoglobin polymer (OxyVita) in a cocktail of hypertonic saline and Hextend as an alternative to standard Hextend. Fluids were either infused by titration to a mean systolic pressure of 60 mmHg or as a single bolus. Parameter estimates derived from both models were assessed for evidence of treatment efficacy and as indicators of short-term survival. A cocktail of hypertonic saline and Hextend was superior to standard Hextend in enhancing survival; however, lactate profiles did not differ between treatments. Regardless of resuscitation regimen, animals surviving to at least 60 min posthemorrhage can be discriminated from nonsurvivors by significantly lower peak lactates (a difference of at least 3 mM; P < 0.001), and all survivors exhibited a decline in lactate with resuscitation. Sequential measurements of lactate over relatively short time frames during resuscitation are of value in assessing both response to resuscitation and short-term mortality.
- 1 July 2007
- Published by Wolters Kluwer Health in Shock
- Vol. 28 (1) , 45-52
LOW-VOLUME RESUSCITATION COCKTAIL EXTENDS SURVIVAL AFTER SEVERE HEMORRHAGIC SHOCK
After severe hemorrhage, low-volume resuscitation with hypertonic fluids is increasingly preferred to more aggressive resuscitation strategies. Oxygen delivery to the tissues may be improved by augmentation with hemoglobin [Hb]-based oxygen-carrying compounds (HBOCs); however, previous studies have reported negative outcomes presumably related to extravasation of tetrameric Hb. The purpose of this study was to evaluate a novel large molecular weight polymer of cross-linked bovine Hb (OxyVita; OXYVITA Inc, New Windsor, NY) in a cocktail of hypertonic saline and Hextend (HX; HBOC-C) as an alternative to standard small-volume resuscitation using Hextend (HX) only. Outcomes were survival to 3 h and duration of MAP support more than 60 mmHg without additional fluid support. Conscious male Long-Evans rats were hemorrhaged to 60% total blood volume over 40 min. There were 4 groups: HBOC-C administered in a pressure-titrated infusion, HX titration, HBOC-C administered as a bolus, and HX bolus. Cardiovascular parameters, arterial gases, acid-base status, metabolites, electrolytes, Hb level, and oxygen saturation were measured at baseline, during each 20% hemorrhage increment, and 1, 2, and 3 h after the initiation of hemorrhage. Small-volume resuscitation with HBOC-C significantly improved survival to 3 h and improved MAP support times regardless of method of administration. However, physiological status at the end of hemorrhage significantly influenced survival regardless of resuscitation treatment. These results suggest that HBOC-augmented hypertonic cocktails are of promise in improving survival and providing target MAP support during small-volume resuscitation. Experimental evaluation of any resuscitation therapy should account for the degree of preexisting physiological compromise before therapy is initiated.
- 1 July 2007
- Published by Wolters Kluwer Health in Shock
- Vol. 28 (1) , 45-52
LOW-VOLUME RESUSCITATION COCKTAIL EXTENDS SURVIVAL AFTER SEVERE HEMORRHAGIC SHOCK
After severe hemorrhage, low-volume resuscitation with hypertonic fluids is increasingly preferred to more aggressive resuscitation strategies. Oxygen delivery to the tissues may be improved by augmentation with hemoglobin [Hb]-based oxygen-carrying compounds (HBOCs); however, previous studies have reported negative outcomes presumably related to extravasation of tetrameric Hb. The purpose of this study was to evaluate a novel large molecular weight polymer of cross-linked bovine Hb (OxyVita; OXYVITA Inc, New Windsor, NY) in a cocktail of hypertonic saline and Hextend (HX; HBOC-C) as an alternative to standard small-volume resuscitation using Hextend (HX) only. Outcomes were survival to 3 h and duration of MAP support more than 60 mmHg without additional fluid support. Conscious male Long-Evans rats were hemorrhaged to 60% total blood volume over 40 min. There were 4 groups: HBOC-C administered in a pressure-titrated infusion, HX titration, HBOC-C administered as a bolus, and HX bolus. Cardiovascular parameters, arterial gases, acid-base status, metabolites, electrolytes, Hb level, and oxygen saturation were measured at baseline, during each 20% hemorrhage increment, and 1, 2, and 3 h after the initiation of hemorrhage. Small-volume resuscitation with HBOC-C significantly improved survival to 3 h and improved MAP support times regardless of method of administration. However, physiological status at the end of hemorrhage significantly influenced survival regardless of resuscitation treatment. These results suggest that HBOC-augmented hypertonic cocktails are of promise in improving survival and providing target MAP support during small-volume resuscitation. Experimental evaluation of any resuscitation therapy should account for the degree of preexisting physiological compromise before therapy is initiated.
- 30 June 2007
- Published by Elsevier in Resuscitation
- Vol. 73 (3) , 446-458
Pharmaceutical metabolic down-regulation by protein synthesis inhibition in a conscious rat model
- 30 June 2007
- Published by Elsevier in Resuscitation
- Vol. 73 (3) , 446-458
Pharmaceutical metabolic down-regulation by protein synthesis inhibition in a conscious rat model